The effects of corticosteroids on cytokine production from asthma lung lymphocytes

International Immunopharmacology

Volumn 23, Issue 2, 2014, Pages 581-584

  Kaur, Manminder ^a   Reynolds, Sophie ^a   Smyth, Lucy J ^b   Simpson, Karen ^c   Hall, Simon ^c   Singh, Dave ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF SALFORD   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; Corticosteroids; Cytokine release; Lymphocytes

Indexed keywords

BRONCHODILATING AGENT; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; GLUCOCORTICOID;

ADULT; ARTICLE; ASTHMA; BRONCHOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LIMIT OF DETECTION; LUNG LAVAGE; LYMPHOCYTE; MALE; SUPERNATANT; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CLINICAL TRIAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; LUNG; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG; LYMPHOCYTES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84913582843     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.10.008     Document Type: Article

References (24)

1. GINA. Global Initiative for Asthma 2010. Available from www.ginasthma.org.
2. Busse WW, Lemanske Jr RF. Asthma. N Engl J Med 2001;344:350-62.
3. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004;202: 175-90.
4. Shaw DE, Berry MA, Hargadon B, McKenna S, Shelley MJ, Green RH, et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 2007;132:1871-5.
5. Cosmi, L., F. Liotta, E. Maggi, S. Romagnani, and F. Annunziato: Th17 cells: new players in asthma pathogenesis. Allergy 66: 989-98.
6. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE, Demedts MG, Verleden GM. Interleukin-17-induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kappaB. J Heart Lung Transplant 2005;24:875-81.
7. Stirling RG, Chung KF. Severe asthma: definition and mechanisms. Allergy 2001;56: 825-40.
8. Bousquet, J., E. Mantzouranis, A.A. Cruz, N. Ait-Khaled, C.E. Baena-Cagnani, E.R. Bleecker, C.E. Brightling, P. Burney, A. Bush, W.W. Busse, T.B. Casale, M. Chan-Yeung, R. Chen, B. Chowdhury, K.F. Chung, R. Dahl, J.M. Drazen, L.M. Fabbri, S.T. Holgate, F. Kauffmann, T. Haahtela, N. Khaltaev, J.P. Kiley, M.R. Masjedi, Y. Mohammad, P. O'Byrne, M.R. Partridge, K.F. Rabe, A. Togias, C. van Weel, S. Wenzel, N. Zhong, and T. Zuberbier: Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 126: 926-38.
9. Grundy S, Kaur M, Plumb J, Reynolds S, Hall S, House D, et al. CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in COPD CD8 cells. Clin Sci 2013;1:1.
10. Goleva, E., L.P. Jackson, M. Gleason, and D.Y. Leung: Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients. J Allergy Clin Immunol 129: 687-693 e1.
11. Nakagome K, Matsushita S, Nagata M. Neutrophilic inflammation in severe asthma. Int Arch Allergy Immunol 2012;1:96-102.
12. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61.
13. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103: 779-88.
14. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-3.
15. Hashimoto T, Kobayashi N, Kajiyama Y, Kaminuma O, Suko M, Mori A. IL-2-induced IL-13 production by allergen-specific human helper T cell clones. Int Arch Allergy Immunol 2006;140(Suppl. 1):51-4.
16. Corrigan CJ, Brown PH, Barnes NC, Tsai JJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991;144:1026-32.
17. Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, et al. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.
18. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S, et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008;133:420-6.
19. Magnan AO, Mely LG, Camilla CA, Badier MM, Montero-Julian FA, Guillot CM, et al. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med 2000; 161:1790-6.
20. Wang YH, Wills-Karp M. The potential role of interleukin-17 in severe asthma. Curr Allergy Asthma Rep 2011;11:388-94.
21. Eustace A, Smyth LJ, Mitchell L, Williamson K, Plumb J, Singh D. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 2011;139: 1089-100.
22. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, et al. IL-17mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006;7:135.
23. Siddiqui S, Gonem S, Wardlaw AJ. Advances in the management of severe asthma. Semin Respir Crit Care Med 2012;33:666-84.
24. Kaur, M., L.J. Smyth, P. Cadden, S. Grundy, D. Ray, J. Plumb, and D. Singh: T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease. Respir Res 13: 20.